TherapeuticsMD (NYSE:TXMD) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of TherapeuticsMD (NYSE:TXMDGet Rating) in a note issued to investors on Tuesday. The firm set a “sell” rating on the stock.

TherapeuticsMD stock opened at $0.28 on Tuesday. TherapeuticsMD has a twelve month low of $0.18 and a twelve month high of $1.39. The firm has a 50-day moving average of $0.30.

TherapeuticsMD Company Profile (Get Rating)

TherapeuticsMD, Inc operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system.

Read More

Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.